Induced pluripotent stem cells as a biopharmaceutical factory for extracellular vesicles

Eur Heart J. 2018 May 21;39(20):1848-1850. doi: 10.1093/eurheartj/ehy097.

Authors

Masataka Nishiga^{1

2}, Hongchao Guo^{1

2}, Joseph C Wu^{1

2

3}

Affiliations

¹ Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA, USA.
² Department of Medicine, Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA, USA.
³ Institute of Stem Cell Biology & Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, USA.

No abstract available

Publication types

Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Biological Products*
Extracellular Vesicles*
Heart Failure*
Humans
Induced Pluripotent Stem Cells*
Pluripotent Stem Cells*

Substances

Biological Products

Grants and funding